Becton, Dickinson and Co. | BDX - Market Capitalization

Stock Price
144.17
Daily Change
-2.14 -1.46%
Monthly
-7.18%
Yearly
-12.70%
Q2 Forecast
146.20

Becton, Dickinson and Co. reported $42.26B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Agilent USD 37.86B 3.64B Dec/2025
Align Technology USD 12.28B 1.07B Mar/2026
AngioDynamics USD 511M 94M Sep/2025
Avanos Medical USD 1.14B 483M May/2026
Baxter International USD 8.67B 1.15B Mar/2026
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 93.26B 48.09B Mar/2026
Cooper Companies USD 15.95B 2.05B Dec/2025
Danaher USD 128.46B 33.24B Mar/2026
Dentsply International USD 2.36B 41M May/2026
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Globus Medical USD 11.69B 3.95B Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 1.03B 301M May/2026
Intuitive Surgical USD 163.73B 37.04B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Masimo USD 6.84B 839M Dec/2025
Stryker USD 125.85B 8.57B Mar/2026
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
WK Kellogg Co USD 11.76B 441.41M May/2026
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026